RhoVac AB Stock Forecast for 2023 - 2025 - 2030
Updated on 04/25/2024
Stock Rating
-9
Price Target
kr0.00
Consensus
-
Downside
-100.00%
Analysts
0
Stock Rating
-9
Downside
-100.00%
Analysts
0
Price Target
kr0.00
RhoVac AB Stock Forecast and Price Target
The average price target for RhoVac AB's stock lately set by several renowned analysts is kr0.00, which would result in a potential downside of approximately 0 if it reaches this mark by December 31, 2024. This estimation is based on a high estimate of kr0.00 and a low estimate of kr0.00. If you're looking to buy RhoVac AB stock, you may also want to check out its rivals.
kr0.00
N/A
-
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SOBI Stock Forecast | Swedish Orphan Biovitrum AB (p... | Outperform |
16
|
kr266.40 | Buy/Sell | kr293.00 | 18.24% |
| VITR Stock Forecast | Vitrolife AB (publ) | Buy |
18
|
kr162.80 | Buy/Sell | kr250.00 | 35.14% |
| BIOA B Stock Forecast | BioArctic AB (publ) | Outperform |
10
|
kr195.50 | Buy/Sell | kr372.40 | 79.03% |
| KARO Stock Forecast | Karo Healthcare AB | - |
12
|
kr60.70 | Buy/Sell | kr40.00 | -100.00% |
| GENO Stock Forecast | Genovis AB (publ.) | Outperform |
16
|
kr26.90 | Buy/Sell | kr75.67 | 87.73% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| VICO Stock Forecast | Vicore Pharma Holding AB (publ... | Buy |
4
|
kr17.18 | Buy/Sell | kr70.75 | 278.35% |
| HNSA Stock Forecast | Hansa Biopharma AB (publ) | Buy |
6
|
kr27.88 | Buy/Sell | kr123.00 | 237.16% |
| XSPRAY Stock Forecast | Xspray Pharma AB (publ) | Outperform |
6
|
kr40.85 | Buy/Sell | kr120.00 | 161.93% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BINV Stock Forecast | BioInvent International AB (pu... | Outperform |
10
|
kr23.20 | Buy/Sell | kr107.00 | 257.76% |
| MERT A Stock Forecast | Mertiva AB (publ) | - |
9
|
kr0.00 | Buy/Sell | kr0.00 | 0.00% |
| IMMNOV Stock Forecast | Immunovia AB (publ) | - |
0
|
kr1.94 | Buy/Sell | kr0.00 | -100.00% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ATORX Stock Forecast | Alligator Bioscience AB (publ) | Outperform |
0
|
kr0.92 | Buy/Sell | kr1.83 | 150.00% |
| CANTA Stock Forecast | Cantargia AB (publ) | Buy |
5
|
kr3.57 | Buy/Sell | kr13.67 | 264.15% |
| XBRANE Stock Forecast | Xbrane Biopharma AB (publ) | Outperform |
5
|
kr0.21 | Buy/Sell | kr116.00 | 185.71% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| IMMU Stock Forecast | Mendus AB (publ) |
9
|
kr0.49 | Buy/Sell | kr1.70 | 267.35% | |
| ACE Stock Forecast | Ascelia Pharma AB (publ) |
0
|
kr9.65 | Buy/Sell | kr19.50 | 1.04% | |
| KDEV Stock Forecast | Karolinska Development AB (pub... |
8
|
kr1.55 | Buy/Sell | kr4.70 | 161.29% |
RhoVac AB EBIT Forecast for 2023 - 2025 - 2030
RhoVac AB's EBIT has seen impressive growth In the last year, rising from kr-47.47M to kr-61.86M – a growth of 30.31%. In the following year, 0 experts forecast that RhoVac AB's EBIT will decrease by 23.26%, to kr-47.47M. In 2030, professionals predict that RhoVac AB's EBIT will decrease by 12.86%, to kr-53.90M.
2022 EBIT Forecast
kr-47471364.00
2023 EBIT Forecast
kr-53383131.20
2024 EBIT Forecast
kr-52667797.24
2025 EBIT Forecast
kr-56284319.32
2026 EBIT Forecast
kr-53256222.94
2027 EBIT Forecast
kr-53366285.80
2028 EBIT Forecast
kr-53197292.56
2029 EBIT Forecast
kr-54225773.55
2030 EBIT Forecast
kr-53902226.43
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ISR Stock Forecast | ISR Immune System Regulation H... | - |
0
|
kr7.43 | Buy/Sell | kr0.00 | -100.00% |
| HAMLET B Stock Forecast | Hamlet BioPharma AB (publ) | - |
0
|
kr2.29 | Buy/Sell | kr0.00 | -100.00% |
| ONCO Stock Forecast | Oncopeptides AB (publ) |
0
|
kr3.22 | Buy/Sell | kr6.90 | 98.76% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| GUARD Stock Forecast | Guard Therapeutics Internation... |
8
|
kr30.60 | Buy/Sell | kr0.23 | 112.42% | |
| IVACC Stock Forecast | Intervacc AB (publ) |
10
|
kr4.06 | Buy/Sell | kr27.00 | 97.04% | |
| SYNACT Stock Forecast | SynAct Pharma AB | - |
7
|
kr6.90 | Buy/Sell | kr15.00 | -100.00% |
.jpg)